Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial.
Suhler EB, Lowder CY, Goldstein DA, Giles T, Lauer AK, Kurz PA, Pasadhika S, Lee ST, de Saint Sardos A, Butler NJ, Tessler HH, Smith JR, Rosenbaum JT.
Suhler EB, et al. Among authors: lee st.
Br J Ophthalmol. 2013 Apr;97(4):481-6. doi: 10.1136/bjophthalmol-2012-302292. Epub 2013 Feb 2.
Br J Ophthalmol. 2013.
PMID: 23376607
Clinical Trial.